Ladenburg Thalmann Financial Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$275K Sell
11,498
-270
-2% -$7.45K ﹤0.01% 2268
2019
Q3
$315K Sell
11,768
-3,132
-21% -$87.9K ﹤0.01% 2132
2019
Q2
$403K Buy
14,900
+6,710
+82% +$210K ﹤0.01% 1921
2019
Q1
$285K Buy
8,190
+538
+7% +$15.5K ﹤0.01% 2134
2018
Q4
$150K Sell
7,652
-458
-6% -$9.42K ﹤0.01% 2455
2018
Q3
$216K Buy
8,110
+586
+8% +$19.1K ﹤0.01% 2257
2018
Q2
$245K Hold
7,524
﹤0.01% 2084
2018
Q1
$245K Buy
7,524
+210
+3% +$9.21K ﹤0.01% 2084
2017
Q4
$356K Buy
7,314
+300
+4% +$15.2K ﹤0.01% 1783
2017
Q3
$379K Buy
7,014
+460
+7% +$27K ﹤0.01% 1646
2017
Q2
$368K Buy
6,554
+11
+0.2% +$441 ﹤0.01% 1589
2017
Q1
$256K Sell
6,543
-605
-8% -$19.3K ﹤0.01% 1740
2016
Q4
$161K Sell
7,148
-1,097
-13% -$21.4K ﹤0.01% 1977
2016
Q3
$187K Buy
8,245
+144
+2% +$3.38K ﹤0.01% 1804
2016
Q2
$191K Buy
8,101
+944
+13% +$23.3K ﹤0.01% 1712
2016
Q1
$146K Sell
7,157
-75
-1% -$2.38K ﹤0.01% 1822
2015
Q4
$372K Buy
7,232
+959
+15% +$46.5K 0.01% 1188
2015
Q3
$267K Buy
6,273
+2,875
+85% +$139K 0.01% 1290
2015
Q2
$154K Buy
3,398
+1,350
+66% +$54.3K ﹤0.01% 1799
2015
Q1
$78K Buy
2,048
+48
+2% +$1.65K ﹤0.01% 2251
2014
Q4
$57K Buy
+2,000
New +$55.6K ﹤0.01% 2287

Other funds holding PTLA

Ladenburg Thalmann Financial Services's PTLA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 2.3% in Q4 2019, selling an estimated $7.45K and leaving 11,498 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

Ladenburg Thalmann Financial Services first reported a position in PTLA in Q4 2014 and has held it in 21 quarters since. The position peaked at $403K in Q2 2019. 224 funds tracked by Wall St. Rank hold PTLA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 11,498 shares of Portola Pharmaceuticals, Inc. worth $275K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 270 Portola Pharmaceuticals, Inc. shares in Q4 2019, an estimated $7.45K.
  • Portola Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2268 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and has held it in 21 quarters since.
  • Ladenburg Thalmann Financial Services's Portola Pharmaceuticals, Inc. position peaked at $403K in Q2 2019.
  • 224 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.